Page last updated: 2024-12-11

lycopodine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5462445
CHEMBL ID3805710
CHEBI ID6597
SCHEMBL ID613890
MeSH IDM0066628

Synonyms (31)

Synonym
(15r)-15-methyllycopodan-5-one
lycopodan-5-one, 15-methyl-, (15r)-
CHEBI:6597 ,
C09883
466-61-5
lycopodine
2p5mu968xw ,
unii-2p5mu968xw
SCHEMBL613890
1,9-ethanobenzo(i)quinolizin-14-one, dodecahydro-11-methyl-, (1s-(1.alpha.,8a.alpha.,9.beta.,11.alpha.,12as*))-
(-)-lycopodine
1,9-ethanobenzo(i)quinolizin-14-one, dodecahydro-11-methyl-, (1s,8ar,9s,11r,12ar)-
lycopodine [mi]
CHEMBL3805710
Q27107261
BCZFSDNVXODRAJ-JTTNIQEDSA-N
(1r,2r,10s,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.01,6.02,13]hexadecan-11-one
(15r)-15-methyllycopodan-5-one, (+/-)-
(+/-)-lycopodine
18688-24-9
1,9-ethanobenzo(i)quinolizin-14-one, dodecahydro-11-methyl-, (1r,8as,9r,11s,12as)-rel-
NTV9A2GW9H ,
lycopodan-5-one, 15-methyl-, (15r)-(+/-)-
unii-ntv9a2gw9h
dl-lycopodine
lycopodine, (+/-)-
HY-114372
CS-0084297
1,9-ethanobenzo(i)quinolizin-14-one, dodecahydro-11-methyl-, (1s-(1alpha,8aalpha,9beta,11alpha,12as*))-
DTXSID201032264
AKOS040740837

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
quinolizidine alkaloid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1300690Inhibition of ACAT in human monocyte derived macrophages assessed as reduction in foam cell formation by measuring acetyl LDL-induced cholesterol ester accumulation at 30 uM after 24 hrs in presence of cholesteryl-[3H]oleate2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Serralongamines B-D, three new Lycopodium alkaloids from Lycopodium serratum var. longipetiolatum, and their inhibitory effects on foam cell formation in macrophages.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.26)18.7374
1990's0 (0.00)18.2507
2000's3 (15.79)29.6817
2010's14 (73.68)24.3611
2020's1 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.47 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]